A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease modelsBettina van Lengerich, Kathryn M. Monroe, Karin Wind et al.|Nature Neuroscience|2023Cited by 227
CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 95
Author Correction: CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 2
Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.Shruti U. Gandhy, Ravi A. Madan, Seth M. Steinberg et al.|Journal of Clinical Oncology|2020Cited by 1